News

Precision for Medicine Expands with New Singapore Office

Precision for Medicine Expands with New Singapore Office

Precision for Medicine Expands Its Global Office Network

Singapore Office Expands APAC Presence to Seven Locations, Delivering Enhanced Local Expertise and Global Scale

Precision for Medicine, a prominent leader in biomarker-driven clinical research and development, has taken a noteworthy step forward by inaugurating a new office in Singapore. This latest opening marks a significant addition to the organization’s influential presence throughout the Asia-Pacific (APAC) region, serving as a vital hub for improved client support and regional growth acceleration.

According to Jing Ping Yeo, Vice President of Clinical Operations, the establishment of the Singapore office represents a crucial investment in operational capabilities and localized expertise across the APAC territory. He emphasized, "By establishing a base in critical markets like Singapore, we equip our clients with improved oversight and execution of clinical trials, ensuring fast-tracked site activity and higher standards in the management of complex, biomarker-driven clinical programs aimed at benefiting patients across the globe."

Singapore's geographical advantage and sophisticated infrastructural framework position it as an ideal site for bolstering Precision's reach across the region, inclusive of markets such as Mainland China, Hong Kong, India, South Korea, Taiwan, and Australia. With a bolstered workforce exceeding 500 dedicated employees, Precision reaffirms its commitment to tackling the intricacies of regional drug development and commercialization more effectively.

For global partners, this expansion solidifies Precision as a unified contract research organization (CRO), thus mitigating the usual complexities associated with managing multiple partnerships. By offering streamlined oversight and clear accountability lines, Precision enhances the reliability and quality of trial delivery. Furthermore, regional clients can leverage these upgraded capabilities to seamlessly introduce innovative therapies into global development routes spanning the U.S. and Europe.

The Precision team is bolstered by respected leaders throughout various APAC regions. Dr. Yeo, who chairs influential bodies such as the Drug Information Association (DIA) Singapore Advisory Committee and the Singapore Clinical Research Professionals Association (SCRP), plays a pivotal role in guiding the region’s operational excellence.

James Cheong, Senior Vice President for the APAC region, remarked, "The launch of our office in Singapore is a strategic milestone in our broader mission to be the go-to partner for precision medicine development, both globally and within the dynamic context of APAC. This operational hub enables us to marry extensive global insights with vital local intelligence, ultimately offering our clients accelerated solutions and profound support."

Echoing these sentiments, Daisy DeWeese-Gatt, President of Clinical Solutions at Precision for Medicine, highlighted the importance of the Singapore office. She stated, "This opening is a foundational event that amplifies Precision's substantial APAC presence. By harmonizing diverse regional data and patient demographics, we hasten the advancement of new medicines, ensuring that therapies effectively cater to real-world diversity and address high unmet medical needs worldwide."

About Precision for Medicine
Precision for Medicine is a pioneering biomarker-driven clinical research and development service organization designed to support life sciences companies in judiciously deploying biomarkers, which are vital for targeting patient-specific treatments more accurately and effectively. With a transformational approach to clinical research, Precision integrates trial design and execution with robust scientific acumen, laboratory expertise, and advanced data intelligence, driving faster clinical development and regulatory approval.

Part of the esteemed Precision Medicine Group, Precision for Medicine boasts a workforce of over 3,700 individuals spread across more than 50 locations worldwide, including North America, Europe, and Asia-Pacific.

Frequently Asked Questions

What is the new office of Precision for Medicine located?

The new office of Precision for Medicine is located in Singapore.

What is the significance of the Singapore office?

The Singapore office enhances Precision's regional presence and allows better support for clients in the APAC region.

How many locations does Precision for Medicine have in APAC?

With the new office, Precision for Medicine now has seven locations in the APAC region.

Who is leading the operations in the new Singapore office?

The office will be overseen by recognized leaders including Jing Ping Yeo, Vice President of Clinical Operations.

What type of services does Precision for Medicine provide?

Precision for Medicine provides biomarker-driven clinical research and development services for life sciences companies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tenant Improvement: Key to Adapting Lease Spaces

Updated Category News Views 1

Adapting Space or Adapting Business? Here's the thing that keeps popping up in commercial real estate: tenant improvement construction. This isn't just modifying a structure—it's about rethinking how businesses operate within a certain space. The HelloNation article gives you the lowdown straight from Bradley Quakenbush of White Oak Commercial Group. When businesses...

Continue Reading
Spooky Suds: House of Horror Meets El Car Wash

Updated Category News Views 0

A Haunted Wash Awaits Miami Drivers Picture this: you're cruising down West Flagler on a regular Wednesday evening, but tonight, you're not just rolling in for a rinse. Nope, this Wednesday night, the wash tunnel at El Car Wash gets downright spooky. It's getting a haunted house makeover with scare actors from the House of Horror. When a Car Wash Becomes a Haunted...

Continue Reading
LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Updated Category News Views 0

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 7

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
DOCS Faces Investor Legal Battle for Alleged Misconduct

Updated Category News Views 0

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Continue Reading
Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 0

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 5

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
Plata Hits $1 Billion ARR in Record Digital Bank Growth

Updated Category News Views 0

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Continue Reading
eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 0

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
Navigating AI Laws: A New Era for Privacy & Security

Updated Category News Views 1

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

Continue Reading

Top 5 Most Recently Viewed Articles

David Deamer Honored with ABRF Award for Groundbreaking Work

Updated Category News Views 66

David Deamer's Remarkable Recognition Renowned scientist David Deamer, Ph.D., has been honored for his extraordinary contributions to biomolecular technologies. This distinguished recognition comes from the Association of Biomolecular Resource Facilities (ABRF), which named Deamer the recipient of their prestigious ABRF Award, an accolade given to those who have made...

Continue Reading
Qualcomm's Stock Faces Challenges Amid Apple Competition

Updated Category News Views 105

Qualcomm's Stock Performance Qualcomm Inc. (NASDAQ: QCOM) is experiencing a decline in its stock price as recent analyst evaluations raise concerns regarding its future earnings potential. This downward trend follows, in part, an important downgrade by analysts highlighting challenges ahead for the company. Understanding the Downgrade KeyBanc analyst John Vinh made...

Continue Reading
Intensity Therapeutics Achieves Nasdaq Compliance Milestone

Updated Category News Views 103

Intensity Therapeutics Regains Nasdaq Compliance Intensity Therapeutics, Inc. (NASDAQ: INTS) is excited to share significant news regarding its compliance status with Nasdaq's minimum stockholders' equity requirement. The company, committed to developing innovative intratumoral cancer therapies, recently received a notification from the Listing Qualifications Staff of The...

Continue Reading
Resmed Inc. Delivers Robust Earnings Growth in Latest Report

Updated Category News Views 147

Strong Financial Performance from Resmed Inc. Resmed Inc. (NYSE: RMD, ASX: RMD) has announced impressive financial results for its latest quarter, indicating clear growth and sustained demand for its innovative health solutions in sleep and breathing fields. The company's revenue saw an encouraging year-over-year increase of 8%, rising to $1.3 billion. Notably, this...

Continue Reading
Fangzhou Unveils Cutting-Edge Leukemia Treatment Platform

Updated Category News Views 189

Fangzhou Brings Otsuka's Ponatinib to Patients Fangzhou Inc., a leader in innovative healthcare solutions, has announced the launch of Otsuka Pharmaceutical's third-generation tyrosine kinase inhibitor. This groundbreaking treatment is known as Ponatinib, also branded as Iclusig® and is now accessible through Fangzhou's online platform. This offering significantly...

Continue Reading